Latest Breaking News On - Jun bao - Page 1 : comparemela.com

Bitterroot Bio and Biotheus Announce Research Collaboration

Collaboration aims to discover novel bispecific proteins targeting immune modulators and inflammatory pathways implicated in cardiovascular disease.

Jun baoPavan cheruvuXiaolin liuBitterroot bio

Bitterroot Bio and Biotheus Announce Research Collaboration to Develop Bispecific Proteins in Cardio-Immunology

Bitterroot Bio and Biotheus Announce Research Collaboration to Develop Bispecific Proteins in Cardio-Immunology
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Jun baoXiaolin liuPavan cheruvuBitterroot bio

Biotheus Enters Into Strategic Partnership with BioNTech to Develop and Commercialize Bispecific Antibody Candidate Targeting PD-L1 and VEGF in Multiple Solid Tumor Indications

Biotheus Enters Into Strategic Partnership with BioNTech to Develop and Commercialize Bispecific Antibody Candidate Targeting PD-L1 and VEGF in Multiple Solid Tumor Indications
kptv.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from kptv.com Daily Mail and Mail on Sunday newspapers.

Fosun pharmaJun baoXiaolin liuRoche groupPrnewswire biotheus incGoby globalBiotheus incBispecific antibody candidateGreater chinaAntitrust improvements actNew technologiesDuality biologics

Biotheus Announces Strategic Research Collaboration and Worldwide License Agreement with BioNTech

/PRNewswire/ Biotheus Inc. ("Biotheus"), a clinical-stage biotech company dedicated to the discovery and development of biologics for oncology and.

Jun baoXiaolin liuBiotheus incChief executive officer

FDA Granted Orphan Drug Designation to IMP4297+TMZ for SCLC

Press release content from Globe Newswire. The AP news staff was not involved in its creation.

United statesHong kongSouth koreaJun baoJunshi biosciencesGoby globalIr teamPr teamDrug administrationOrphan drug designationCancer treatmentLung cancerGlobe newswire